Dihydroergotamine nasal and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Dihydroergotamine nasal and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Lithium ER
- Dihydroergotamine nasal-Lithium Oral Solution
- Dihydroergotamine nasal-Lithium Salts
- Dihydroergotamine nasal-Lithium Syrup and Oral Solution
- Dihydroergotamine nasal-Lithobid
- Dihydroergotamine nasal-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Lithium Controlled-Release and Extended-Release Tablets-Dilacor XR
- Lithium Controlled-Release and Extended-Release Tablets-Dilantin
- Lithium Controlled-Release and Extended-Release Tablets-Dilantin Infatabs
- Lithium Controlled-Release and Extended-Release Tablets-Dilantin injection
- Lithium Controlled-Release and Extended-Release Tablets-Dilantin Kapseals